Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance, The Oncologist

Bookmark
Add to Folder

Cite
Social

Loading next page...

/lp/oxford-university-press/gamma-secretase-inhibitors-in-cancer-a-current-perspective-on-clinical-g3CUZqSNNd

C. Curry, L. Reed, T. Golde, L. Miele, B. Nickoloff, K. Foreman (2005)
Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells
Oncogene, 24
Wei He, L. Luistro, D. Carvajal, M. Smith, T. Nevins, Xuefeng Yin, James Cai, B. Higgins, K. Kolinsky, C. Rizzo, K. Packman, D. Heimbrook, J. Boylan (2011)
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ‐secretase inhibitor, RO4929097
Molecular Oncology, 5
C. Efferson, C. Winkelmann, C. Ware, T. Sullivan, S. Giampaoli, J. Tammam, Shailendra Patel, G. Mesiti, J. Reilly, R. Gibson, C. Buser, T. Yeatman, D. Coppola, C. Winter, E. Clark, G. Draetta, P. Strack, P. Majumder (2010)
Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
Cancer research, 70 6
A. Gavai, C. Quesnelle, Derek Norris, W. Han, P. Gill, Weifang Shan, A. Balog, Ke Chen, A. Tebben, R. Rampulla, Dauh-Rurng Wu, Yingru Zhang, A. Mathur, Ronald White, A. Rose, Haiqing Wang, Zheng Yang, A. Ranasinghe, C. D’arienzo, Victor Guarino, L. Xiao, Ching-Ya Su, Gerry Everlof, V. Arora, D. Shen, M. Cvijic, Krista Menard, M. Wen, J. Meredith, G. Trainor, L. Lombardo, R. Olson, P. Baran, J. Hunt, G. Vite, B. Fischer, R. Westhouse, F. Lee (2015)
Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors.
ACS medicinal chemistry letters, 6 5
M. Mizuma, M. Mizuma, Z. Rasheed, S. Yabuuchi, N. Omura, Nathaniel Campbell, R. Wilde, Elizabeth Oliveira, Qing Zhang, O. Puig, W. Matsui, M. Hidalgo, A. Maitra, N. Rajeshkumar (2012)
The Gamma Secretase Inhibitor MRK-003 Attenuates Pancreatic Cancer Growth in Preclinical Models
Molecular Cancer Therapeutics, 11
Tong Li, H. Wen, Cory Brayton, Pritam Das, Lisa Smithson, A. Fauq, Xing Fan, B. Crain, D. Price, T. Golde, C. Eberhart, P. Wong (2007)
Epidermal Growth Factor Receptor and Notch Pathways Participate in the Tumor Suppressor Function of γ-Secretase*
Journal of Biological Chemistry, 282
Zhilu Li, Cheng Chen, Yuan Yang, Cheng Wang, Ting Yang, Xin Yang, Shengchun Liu (2015)
Gamma secretase inhibitor enhances sensitivity to doxorubicin in MDA-MB-231 cells.
International journal of clinical and experimental pathology, 8 5
L. Girard, Z. Hanna, N. Beaulieu, C. Hoemann, C. Simard, C. Kozak, P. Jolicoeur, P. Jolicoeur (1996)
Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis.
Genes & development, 10 15
(2014)
Three-dimensional structure of human gamma-secretase
I Brana, R Berger, T Golan (2014)
A parallel‐arm phase I trial of the humanised anti‐IGF‐1R antibody dalotuzumab in combination with the AKT inhibitor MK‐2206, the mTOR inhibitor ridaforolimus, or the Notch inhibitor MK‐0752, in patients with advanced solid tumours
Br J Cancer, 111
Tanya Stoyanova, M. Riedinger, Shu Lin, Claire Faltermeier, Bryan Smith, Kelvin Zhang, Catherine Going, A. Goldstein, John Lee, J. Drake, M. Rice, E. Hsu, B. Nowroozizadeh, Brandon Castor, Sandra Orellana, Steven Blum, D. Cheng, K. Pienta, R. Reiter, Sharon Pitteri, Jiaoti Huang, Owen Witte (2016)
Activation of Notch1 synergizes with multiple pathways in promoting castration-resistant prostate cancer
Proceedings of the National Academy of Sciences, 113
N. Schor (2011)
What the halted phase III γ‐secretase inhibitor trial may (or may not) be telling us
Annals of Neurology, 69
H. Woo, Jong-sung Park, A. Gwon, T. Arumugam, D. Jo (2009)
Alzheimer's disease and Notch signaling.
Biochemical and biophysical research communications, 390 4
H. Choi, Hifzur Siddique, Mengmei Zheng, Y. Kou, Da-Wei Yeh, T. Machida, Chia-Lin Chen, D. Kumar, V. Punj, Peleg Winer, Alejandro Pita, L. Sher, S. Tahara, R. Ray, Chengyu Liang, Lin Chen, H. Tsukamoto, K. Machida (2020)
p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs
Nature Communications, 11
(2016)
Self-renewal of CD133(hi) cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer
G. Searfoss, W. Jordan, D. Calligaro, E. Galbreath, L. Schirtzinger, B. Berridge, H. Gao, M. Higgins, P. May, T. Ryan (2003)
Adipsin, a Biomarker of Gastrointestinal Toxicity Mediated by a Functional γ-Secretase Inhibitor*
Journal of Biological Chemistry, 278
J. Strosberg, T. Yeatman, J. Weber, D. Coppola, M. Schell, G. Han, K. Almhanna, R. Kim, T. Valone, Helen Jump, D. Sullivan (2012)
A phase II study of RO4929097 in metastatic colorectal cancer.
European journal of cancer, 48 7
Weizhou Zhang, S. Grivennikov (2013)
Top Notch cancer stem cells by paracrine NF-κB signaling in breast cancer
Breast Cancer Research : BCR, 15
W. Xiao, Xiaoyun Chen, M. He (2014)
Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways.
Molecular medicine reports, 10 1
Means-Powell (2012)
A phase Ib dose escalation trial of RO4929097 (a γ-secretase inhibitor) in combination with exemestane in patients with ER + metastatic breast cancer
Cancer Res, 72
Zhao (2008)
2927
J Biol Chem, 283
L. Ellisen, J. Bird, D. West, A. Soreng, T. Reynolds, Stephen Smith, J. Sklar (1991)
TAN-1, the human hom*olog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms
Cell, 66
R. Meng, C. Shelton, Yue-Ming Li, L. Qin, D. Notterman, P. Paty, G. Schwartz (2009)
gamma-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity.
Cancer research, 69 2
A. Tolcher, W. Messersmith, S. Mikulski, K. Papadopoulos, E. Kwak, D. Gibbon, A. Patnaik, G. Falchook, A. Dasari, G. Shapiro, J. Boylan, Zhi-xin Xu, Ka Wang, A. Koehler, James Song, S. Middleton, J. Deutsch, M. DeMario, R. Kurzrock, J. Wheler (2012)
Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 19
Byron Zhao, Mei Yu, Martin Neitzel, Jennifer Marugg, J. Jagodziński, Mike Lee, K. Hu, D. Schenk, T. Yednock, G. Basi (2008)
Identification of gamma-secretase inhibitor potency determinants on presenilin.
The Journal of biological chemistry, 283 5
A firstin-human phase I study of the oral Notch inhibitor, LY900009
A. Puisieux, T. Brabletz, J. Caramel (2014)
Oncogenic roles of EMT-inducing transcription factors
Nature Cell Biology, 16
Feng Gu, Yongjie Ma, Zuping Zhang, Jinghui Zhao, Hisayuki Kobayashi, Lun Zhang, L. Fu (2010)
Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma.
Oncology reports, 23 3
Sudhir Rao, J. O'neil, C. Liberator, J. Hardwick, Xudong Dai, Theresa Zhang, Edyta Tyminski, Jing Yuan, N. Kohl, V. Richon, L. Ploeg, P. Carroll, G. Draetta, A. Look, P. Strack, C. Winter (2009)
Inhibition of NOTCH signaling by gamma secretase inhibitor engages the RB pathway and elicits cell cycle exit in T-cell acute lymphoblastic leukemia cells.
Cancer research, 69 7
Peter Andersen, Hideki Uosaki, L. Shenje, Chulan Kwon (2012)
Non-canonical Notch signaling: emerging role and mechanism.
Trends in cell biology, 22 5
Yang (2018)
34996
Oncotarget, 9
L. Charbonnier, Sen Wang, Peter Georgiev, Esen Sefik, T. Chatila (2015)
Control of peripheral tolerance by regulatory T cell-intrinsic Notch signaling
Nature immunology, 16
Long Hai, Chen Zhang, Tao Li, Xingchen Zhou, Bo Liu, Shuai Li, Meng Zhu, Yu Lin, Sheng-ping Yu, Kai Zhang, Bingcheng Ren, Hao-lang Ming, Yubao Huang, Lei Chen, Pengfei Zhao, Hua Zhou, Tao Jiang, Xuejun Yang (2018)
Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway
Cell Death & Disease, 9
A. Weng, A. Ferrando, W. Lee, John Morris, L. Silverman, Cheryll Sanchez-Irizarry, S. Blacklow, A. Look, J. Aster (2004)
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Science, 306
W. Messersmith, G. Shapiro, J. Cleary, A. Jimeno, A. Dasari, B. Huang, N. Shaik, R. Cesari, Xianxian Zheng, Jennifer Reynolds, P. English, K. Mclachlan, K. Kern, P. LoRusso (2014)
A Phase I, Dose-Finding Study in Patients with Advanced Solid Malignancies of the Oral γ-Secretase Inhibitor PF-03084014
Clinical Cancer Research, 21
(2011)
Gammasecretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro
Martone (2009)
598
J Pharmacol, 331
M. Reedijk, S. Odorcic, Lynn Chang, Hui Zhang, N. Miller, D. McCready, G. Lockwood, S. Egan (2005)
See Also
Georgia alert; a look at education's role today, 1966 October - 1967 July
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
Cancer research, 65 18
A. Haapasalo, D. Kovacs (2011)
The many substrates of presenilin/γ-secretase.
Journal of Alzheimer's disease : JAD, 25 1
M. Locatelli, P. Aftimos, E. Dees, P. LoRusso, M. Pegram, A. Awada, B. Huang, R. Cesari, Yuqiu Jiang, M. Shaik, K. Kern, G. Curigliano (2016)
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer
Oncotarget, 8
Tsuyoshi Ozawa, S. Kazama, T. Akiyoshi, K. Murono, S. Yoneyama, Toshiaki Tanaka, J. Tanaka, T. Kiyomatsu, K. Kawai, H. Nozawa, T. Kanazawa, H. Yamaguchi, S. Ishihara, E. Sunami, J. Kitayama, Teppei Morikawa, M. f*ckayama, Toshiaki Watanabe (2014)
Nuclear Notch3 Expression is Associated with Tumor Recurrence in Patients with Stage II and III Colorectal Cancer
Annals of Surgical Oncology, 21
Han (2009)
R57
Breast Cancer Res, 11
L. Hoffman, M. Fouladi, J. Olson, Vinay Daryani, C. Stewart, C. Wetmore, M. Koçak, A. Onar-Thomas, L. Wagner, S. Gururangan, R. Packer, S. Blaney, A. Gajjar, L. Kun, J. Boyett, R. Gilbertson (2015)
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Child's Nervous System, 31
R. Kovall, S. Blacklow (2010)
Mechanistic insights into Notch receptor signaling from structural and biochemical studies.
Current topics in developmental biology, 92
S. Kummar, G. Coyne, K. Do, B. Turkbey, P. Meltzer, E. Polley, P. Choyke, R. Meehan, R. Vilimas, Yvonne Horneffer, L. Juwara, A. Lih, Alok Choudhary, S. Mitchell, L. Helman, J. Doroshow, A. Chen (2017)
Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 14
Yu-Peng Liu, Chih-Jen Yang, Ming-Shyan Huang, C. Yeh, A. Wu, Yu-Cheng Lee, T. Lai, C. Lee, Y. Hsiao, Jean Lu, Chia-Ning Shen, P. Lu, M. Hsiao (2013)
Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.
Cancer research, 73 1
Pant (2016)
1
Eur J Cancer, 56
V. Coric, C. Dyck, S. Salloway, N. Andreasen, M. Brody, R. Richter, H. Soininen, S. Thein, T. Shiovitz, G. Pilcher, Susan Colby, L. Rollin, R. Dockens, C. Pachai, E. Portelius, U. Andreasson, K. Blennow, H. Soares, C. Albright, H. Feldman, R. Berman (2012)
Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
Archives of neurology, 69 11
Gold (2013)
31
J Clin Oncol, 8104a
V. Villalobos, Francis Hall, A. Jimeno, L. Gore, K. Kern, R. Cesari, B. Huang, J. Schowinsky, P. Blatchford, Brianna Hoffner, A. Elias, W. Messersmith (2018)
Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor
Annals of Surgical Oncology, 25
B. Thompson, S. Buonamici, M. Sulis, Teresa Palomero, T. Vilimas, G. Basso, A. Ferrando, I. Aifantis (2007)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
The Journal of Experimental Medicine, 204
(2019)
Gamma-secretasedependent signaling of receptor tyrosine kinases
Lu (2014)
166
Nature, 512
W He, L Luistro, D Carvajal (2011)
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the gamma‐secretase inhibitor
RO4929097. Mol Oncol, 5
Nagarajan Nandagopal, Leah Santat, Lauren LeBon, D. Sprinzak, Marianne Bronner, M. Elowitz (2018)
Dynamic Ligand Discrimination in the Notch Signaling Pathway
Cell, 172
Olivier Meurette, P. Mehlen (2018)
Notch Signaling in the Tumor Microenvironment.
Cancer cell, 34 4
I. Díaz-Padilla, M. Wilson, B. Clarke, H. Hirte, S. Welch, H. Mackay, J. Biagi, M. Reedijk, J. Weberpals, G. Fleming, Lisa Wang, Geoffrey Liu, Chengya Zhou, C. Blattler, S. Ivy, A. Oza (2015)
A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia.
Gynecologic oncology, 137 2
D. Chu, Z. Zhang, Y. Zhou, W. Wang, Y. Li, H. Zhang, G. Dong, Q. Zhao, G. Ji (2011)
Notch1 and Notch2 have opposite prognostic effects on patients with colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology, 22 11
Yi-Yang Hu, M. Zheng, Gang Cheng, Liang Li, Liang Liang, Fang Gao, Ya-Ning Wei, L. Fu, Hua Han (2011)
Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells
BMC Cancer, 11
K. Gold, L. Byers, Youhong Fan, J. Fujimoto, W. Tse, J. Lee, Sanjay Gupta, I. Wistuba, D. Stewart, D. Gibbons (2013)
A phase I/II trial combining erlotinib with gamma secretase inhibitor RO4929097 in advanced non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology, 31
Y. Miyamoto, A. Maitra, B. Ghosh, U. Zechner, P. Argani, C. Iacobuzio-Donahue, V. Sriuranpong, T. Iso, I. Meszoely, M. Wolfe, R. Hruban, D. Ball, R. Schmid, S. Leach (2003)
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis.
Cancer cell, 3 6
Gertsik (2014)
342
Front Aging Neurosci, 6
Jia Lu, X. Ye, F. Fan, L. Xia, R. Bhattacharya, S. Bellister, F. Tozzi, E. Sceusi, Yunfei Zhou, I. Tachibana, D. Maru, D. Hawke, J. Rak, Sendurai Mani, P. Zweidler-McKay, L. Ellis (2013)
Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.
Cancer cell, 23 2
N. Gupta, Zhihua Xu, A. El-Sehemy, H. Steed, YangXin Fu (2013)
Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gynecologic oncology, 130 1
S. Richter, Philippe Bédard, E. Chen, B. Clarke, B. Tran, S. Hotte, A. Stathis, H. Hirte, Albiruni, R. Razak, M. Reedijk, Zhuo Chen, B. Cohen, Wen-jiang Zhang, L. Wang, Percy, Ivy, M. Moore, A. Oza, L. Siu, E. Mcwhirter, S. Richter, Philippe Bédard, E. Chen, B Tran, Stathis, Razak, W. Zhang, M. Moore, Oza, L. Siu, B. Clarke, S. Hotte, H. Hirte, E. Mcwhirter, M. Reedijk, Z. Chen, B. Cohen, L. Wang, S. Ivy (2013)
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
Investigational New Drugs, 32
Hiromi Shimojo, T. Ohtsuka, R. Kageyama (2011)
Dynamic Expression of Notch Signaling Genes in Neural Stem/Progenitor Cells
Frontiers in Neuroscience, 5
N. Loconte, A. Razak, P. Ivy, Amye Tevaarwerk, Rachael Leverence, J. Kolesar, L. Siu, S. Lubner, D. Mulkerin, W. Schelman, D. Deming, K. Holen, L. Carmichael, J. Eickhoff, Glenn Liu (2015)
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors
Investigational New Drugs, 33
C. Huynh, L. Poliseno, M. Segura, R. Medicherla, A. Haimovic, S. Menéndez, S. Shang, A. Pavlick, Y. Shao, F. Darvishian, J. Boylan, I. Osman, E. Hernando (2011)
The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
PLoS ONE, 6
K. Skubitz (2017)
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
Mayo Clinic Proceedings, 92
A. Jesus-Acosta, D. Laheru, A. Maitra, J. Arcaroli, M. Rudek, A. Dasari, P. Blatchford, Kevin Quackenbush, W. Messersmith (2014)
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma
Investigational New Drugs, 32
Ahmed Alniaimi, Kristin Demorest-Hayes, V. Alexander, S. Seo, D. Yang, S. Rose (2015)
Increased Notch1 Expression Is Associated With Poor Overall Survival in Patients With Ovarian Cancer
International Journal of Gynecologic Cancer, 25
Y. Mitani, J. Yarimizu, K. Saita, H. Uchino, H. Akashiba, Y. sh*taka, K. Ni, N. Matsuoka (2012)
Differential Effects between γ-Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
The Journal of Neuroscience, 32
Brana (2014)
1932
Br J Cancer, 111
P. Wei, Marlena Walls, M. Qiu, R. Ding, R. Denlinger, A. Wong, K. Tsaparikos, J. Jani, N. Hosea, Michelle Sands, S. Randolph, T. Smeal (2010)
Evaluation of Selective γ-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Molecular Cancer Therapeutics, 9
H. Pathak, A. Rangarajan (2011)
Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
Cell Death & Disease, 2
L. Sang, H. Coller, James Roberts (2008)
Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1
Science, 321
M. Mazzone, L. Selfors, J. Albeck, M. Overholtzer, S. Šale, D. Carroll, D. Pandya, Yiling Lu, G. Mills, J. Aster, S. Artavanis-Tsakonas, J. Brugge (2010)
Dose-dependent induction of distinct phenotypic responses to Notch pathway activation in mammary epithelial cells
Proceedings of the National Academy of Sciences, 107
S. Pece, M. Serresi, E. Santolini, M. Capra, E. Hulleman, V. Galimberti, S. Zurrida, P. Maisonneuve, G. Viale, P. Fiore (2004)
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis
The Journal of Cell Biology, 167
Lei Sun, J. Ke, Zhen He, Zexian Chen, Qinghua Huang, Wen-xia Ai, Guoqiang Wang, Yisheng Wei, Xiangcai Zou, S. Zhang, P. Lan, Chuyuan Hong (2017)
HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
Journal of Cancer, 8
Yong Ran, Fokhrul Hossain, A. Pannuti, C. Lessard, Gabriela Ladd, J. Jung, L. Minter, B. Osborne, L. Miele, T. Golde (2017)
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
EMBO Molecular Medicine, 9
Sylvia Lee, J. Moon, B. Redman, T. Chidiac, L. Flaherty, Y. Zha, M. Othus, A. Ribas, V. Sondak, T. Gajewski, K. Margolin (2015)
Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933
Cancer, 121
M. Fouladi, C. Stewart, J. Olson, L. Wagner, A. Onar-Thomas, M. Koçak, R. Packer, S. Goldman, S. Gururangan, A. Gajjar, T. Demuth, L. Kun, J. Boyett, R. Gilbertson (2011)
Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 26
Hui Shang, D. Braggio, Ya-Jung Lee, Ghadah Sannaa, C. Creighton, Svetlana Bolshakov, A. Lazar, D. Lev, R. Pollock (2015)
Targeting the notch pathway: A potential therapeutic approach for desmoid tumors
Cancer, 121
H. Lewis, B. Revuelta, A. Nadin, J. Neduvelil, Tim Harrison, S. Pollack, M. Shearman (2003)
Catalytic Site-Directed γ-Secretase Complex Inhibitors Do Not Discriminate Pharmacologically between Notch S3 and β-APP Cleavages
Biochemistry, 42
He Wang, Yili Chen, C. Castillo, O. Yilmaz, V. Deshpande (2013)
Heterogeneity in signaling pathways of gastroenteropancreatic neuroendocrine tumors: a critical look at notch signaling pathway
Modern Pathology, 26
Mingyi Wang, Xiangdong Ma, Jian Wang, Lin Wang, Yu Wang (2014)
Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
International journal of oncology, 44 4
A. Diévart, N. Beaulieu, P. Jolicoeur (1999)
Involvement of Notch1 in the development of mouse mammary tumors
Oncogene, 18
Jiang (2011)
140
Chin J Cancer Res, 23
N. Gertsik, D. Chiu, Yue-Ming Li (2014)
Complex regulation of γ-secretase: from obligatory to modulatory subunits
Frontiers in Aging Neuroscience, 6
Dong Wang, Jiahui Xu, Bingjie Liu, Xueyan He, Lei Zhou, Xin Hu, Feng Qiao, A. Zhang, Xiaojun Xu, Huafeng Zhang, M. Wicha, Lixing Zhang, Z. Shao, Suling Liu (2017)
IL6 blockade potentiates the anti-tumor effects of γ-secretase inhibitors in Notch3-expressing breast cancer
Cell Death and Differentiation, 25
C. Siebel, U. Lendahl (2017)
Notch Signaling in Development, Tissue Homeostasis, and Disease.
Physiological reviews, 97 4
(2008)
Substrate specificity of gamma-secretase and other intramembrane proteases
Lu-chun Li, Dong-lin Wang, Yong-zhong Wu, Weiqi Nian, Zhijuan Wu, Yan Li, Huiwen Ma, Jianghe Shao (2015)
Gastric tumor-initiating CD44+ cells and epithelial-mesenchymal transition are inhibited by γ-secretase inhibitor DAPT.
Oncology letters, 10 5
DM Barten, JE Meredith, R Zaczek (2006)
Γ‐secretase inhibitors for Alzheimer's disease: Balancing efficacy and toxicity
Drugs R D, 7
A. Schott, M. Landis, G. Dontu, K. Griffith, R. Layman, I. Krop, Lacey Paskett, H. Wong, L. Dobrolecki, M. Lewis, A. Froehlich, Jaya Paranilam, D. Hayes, M. Wicha, Jenny Chang (2013)
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Clinical Cancer Research, 19
I. Krop, T. Demuth, T. Guthrie, P. Wen, W. Mason, P. Chinnaiyan, N. Butowski, M. Groves, S. Kesari, S. Freedman, S. Blackman, J. Watters, A. Loboda, A. Podtelezhnikov, J. Lunceford, Cong Chen, M. Giannotti, J. Hing, R. Beckman, P. LoRusso (2012)
Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30 19
I. Espinoza, L. Miele (2013)
Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Cancer letters, 341 1
Fen Chen, A. Pisklakova, Ming Li, R. Baz, D. Sullivan, Yulia Nefedova (2011)
Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma
Cellular Oncology, 34
R. Martone, Hua Zhou, K. Atchison, T. Comery, Jane Xu, Xinyi Huang, Xioahai Gong, Mei Jin, A. Kreft, B. Harrison, S. Mayer, S. Aschmies, C. Gonzales, M. Zaleska, David Riddell, E. Wagner, P. Lu, Shaiu-Ching Sun, J. Sonnenberg‐Reines, A. Oganesian, K. Adkins, Michael Leach, David Clarke, D. Huryn, M. Abou-Gharbia, R. Magolda, J. Bard, G. Frick, S. Raje, S. Forlow, C. Balliet, M. Burczynski, Peter Reinhart, Hong Wan, M. Pangalos, J. Jacobsen (2009)
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease
Journal of Pharmacology and Experimental Therapeutics, 331
S. Sahebjam, Philippe Bédard, V. Castonguay, Z. Chen, M. Reedijk, G. Liu, B. Cohen, W. Zhang, B. Clarke, T. Zhang, S. Kamel‐Reid, H. Chen, S. Ivy, A. Razak, A. Oza, E. Chen, H. Hirte, A. McGarrity, L. Wang, L. Siu, S. Hotte (2012)
A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503)
British Journal of Cancer, 109
Thant Zhu, Mark Costello, Caroline Talsma, Callie Flack, Jessica Crowley, Lisa Hamm, Xiaobing He, S. Hervey-Jumper, J. Heth, K. Muraszko, F. DiMeco, A. Vescovi, Xing Fan (2011)
Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells.
Cancer research, 71 18
Merilahti (2019)
151
Oncogene, 38
D. Barten, J. Meredith, R. Zaczek, J. Houston, C. Albright (2006)
γ-Secretase Inhibitors for Alzheimer’s Disease
Drugs in R&D, 7
Xun Yuan, Hua Wu, Hanxiao Xu, N. Han, Q. Chu, Shiying Yu, Yuan Chen, Kongming Wu (2015)
Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis
Scientific Reports, 5
D. Cui, Jinlu Dai, Jill Keller, A. Mizokami, Shujie Xia, E. Keller (2015)
Notch Pathway Inhibition Using PF-03084014, a γ-Secretase Inhibitor (GSI), Enhances the Antitumor Effect of Docetaxel in Prostate Cancer
Clinical Cancer Research, 21
Daniel DeAngelo, Richard Stone, Lewis Silverman, Wendy Stock, Eyal Attar, I. Fearen, Aimee Dallob, Catherine Matthews, James Stone, S. Freedman, Jon Aster (2006)
A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/lymphoma (T-ALL) and other leukemias.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 18_suppl
Li (2015)
4378
Int J Clin Pathol, 8
N. Saito, Jun Fu, Siyuan Zheng, Jun Yao, Shuzhen Wang, Diane Liu, Ying Yuan, E. Sulman, F. Lang, H. Colman, R. Verhaak, W. Yung, D. Koul (2014)
A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells
STEM CELLS, 32
(2009)
The cytotoxicity of gamma-secretase inhibitor i to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition
(2017)
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women.
Obstetrics and gynecology, 130 1
Runsheng Wang, Phuong Tang, Pei Wang, R. Boissy, Hui Zheng (2006)
Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation.
Proceedings of the National Academy of Sciences of the United States of America, 103 2
Jiesi Zhou, Saket Jain, A. Azad, Xia Xu, Hai Yu, Zhihua Xu, R. Godbout, YangXin Fu (2016)
Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
Cellular signalling, 28 8
J. Cook, K. Wildsmith, D. Gilberto, M. Holahan, G. Kinney, Parker Mathers, Maria Michener, Eric Price, M. Shearman, A. Simon, Jennifer Wang, Guoxin Wu, K. Yarasheski, R. Bateman (2010)
Acute γ-Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid-β Production to Alternative APP Fragments without Amyloid-β Rebound
The Journal of Neuroscience, 30
C. Lessard, Edgardo Rodríguez, Thomas Ladd, L. Minter, B. Osborne, L. Miele, T. Golde, Yong Ran (2019)
Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells
The Journal of Biological Chemistry, 294
Katherine Morgan, B. Fischer, F. Lee, J. Shah, J. Bertino, J. Rosenfeld, Amartya Singh, Hossein Khiabanian, Sharon Pine (2017)
Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Pacl*taxel in Lung Adenocarcinoma
Molecular Cancer Therapeutics, 16
D. Peng, T. Tanikawa, Wei Li, Lili Zhao, Linda Vatan, Wojciech Szeliga, Shanshan Wan, Shuang Wei, Yin Wang, Yan Liu, E. Starosławska, F. Szubstarski, J. Roliński, E. Grywalska, A. Stanisławek, W. Polkowski, A. Kurylcio, C. Kleer, A. Chang, M. Wicha, M. Sabel, W. Zou, Ilona Kryczek (2016)
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
Cancer research, 76 11
Beel (2008)
1311
Cell Mol Life Sci, 65
Lanz (2010)
269
J Pharmacol, 334
Rosa Sierra, P. Thevenot, Patrick Raber, Yan Cui, C. Parsons, A. Ochoa, J. Trillo-Tinoco, L. Valle, P. Rodriguez (2014)
Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
Cancer Immunology Research, 2
J. Means-Powell, I. Mayer, R. Ismail-Khan, L. Valle, D. Tonetti, V. Abramson, Melinda Sanders, R. Lush, C. Sorrentino, Samarpan Majumder, L. Miele (2021)
A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER+Metastatic Breast Cancer (MBC).
Clinical breast cancer
E. Chiorean, P. LoRusso, R. Strother, J. Diamond, A. Younger, W. Messersmith, L. Adriaens, Liming Liu, R. Kao, A. Dicioccio, A. Kostić, R. Leek, A. Harris, A. Jimeno (2015)
A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
Clinical Cancer Research, 21
Cathy Zhang, Zhengming Yan, Qing Zong, Douglas Fang, Cory Painter, Qin Zhang, E. Chen, Maruja Lira, A. John-Baptiste, J. Christensen (2013)
Synergistic Effect of the γ‐Secretase Inhibitor PF‐03084014 and Docetaxel in Breast Cancer Models
STEM CELLS Translational Medicine, 2
M. Pazos, D. Abramovich, A. Bechis, P. Accialini, F. Parborell, M. Tesone, G. Irusta (2017)
Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines
Molecular and Cellular Endocrinology, 440
T. Golde, E. Koo, K. Felsenstein, B. Osborne, L. Miele (2013)
γ-Secretase inhibitors and modulators.
Biochimica et biophysica acta, 1828 12
V. Ramakrishnan, S. Ansell, J. Haug, D. Grote, T. Kimlinger, M. Stenson, M. Timm, L. Wellik, T. Halling, S. Rajkumar, S. Kumar (2012)
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
Leukemia, 26
Jeon (2019)
4614
Oncol Lett, 17
Ruixue Yuan, J. Ke, Lei Sun, Zhen He, Y. Zou, Xiaosheng He, Yu-feng Chen, Xianrui Wu, Z. Cai, Lei Wang, Jianping Wang, Xinjuan Fan, Xiaojian Wu, P. Lan (2015)
HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer
Clinical & Experimental Metastasis, 32
P. Candy, Michael Phillips, Andrew Redfern, Andrew Redfern, Shane Colley, J. Davidson, J. Davidson, Lisa Stuart, Benjamin Wood, Nikolajs Zeps, P. Leedman (2013)
Notch-induced transcription factors are predictive of survival and 5-fluorouracil response in colorectal cancer patients
British Journal of Cancer, 109
Zhiwei Wang, Yiwei Li, Sanjeev Banerjee, F. Sarkar (2009)
Emerging role of Notch in stem cells and cancer.
Cancer letters, 279 1
N. Haines, K. Irvine (2003)
Glycosylation regulates Notch signalling
Nature Reviews Molecular Cell Biology, 4
R. Doody, R. Raman, M. Farlow, T. Iwatsubo, B. Vellas, S. Joffe, K. Kieburtz, F. He, Xiaoying Sun, Ronald Thomas, P. Aisen, E. Siemers, G. Sethuraman, R. Mohs (2013)
A phase 3 trial of semagacestat for treatment of Alzheimer's disease.
The New England journal of medicine, 369 4
Y. Matsuno, A. Coelho, G. Jarai, J. Westwick, C. Hogaboam (2012)
Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1.
The international journal of biochemistry & cell biology, 44 5
Y. Jeon, M. Ha, Sung Kim, Mun Kim, Chi-Seung Lee, Chang-Kyu Oh, Myoung-Eun Han, Sae-Ock Oh, Y. Kim (2019)
Evaluation of the prognostic significances of γ-secretase genes in pancreatic cancer
Oncology Letters, 17
B. Strooper, W. Annaert (2010)
Novel research horizons for presenilins and γ-secretases in cell biology and disease.
Annual review of cell and developmental biology, 26
M. Kondratyev, A. Krešo, R. Hallett, A. Girgis-Gabardo, M. Barcelon, D. Ilieva, C. Ware, P. Majumder, J. Hassell (2012)
Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer
Oncogene, 31
Gu (2010)
671
Oncol Rep, 23
S. Xiong, Rong-hua Wang, Qian Chen, Jing Luo, Jinlin Wang, Zhenxiong Zhao, Yawen Li, Yun Wang, Xiju Wang, Bin Cheng (2018)
Cancer-associated fibroblasts promote stem cell-like properties of hepatocellular carcinoma cells through IL-6/STAT3/Notch signaling.
American journal of cancer research, 8 2
M. Monticone, Emanuela Biollo, Andrea Fabiano, M. Fabbi, A. Daga, F. Romeo, M. Maffei, A. Melotti, W. Giaretti, G. Corte, P. Castagnola (2009)
z-Leucinyl-Leucinyl-Norleucinal Induces Apoptosis of Human Glioblastoma Tumor–Initiating Cells by Proteasome Inhibition and Mitotic Arrest Response
Molecular Cancer Research, 7
S Pant, SF Jones, CD Kurkjian (2016)
A first‐in‐human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
Eur J Cancer, 56
Brendan D'Souza, A. Miyamoto, G. Weinmaster (2008)
The many facets of Notch ligands
Oncogene, 27
Mahnaz Janghorban, L. Xin, J. Rosen, X. Zhang (2018)
Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target?
Frontiers in Immunology, 9
I. Díaz-Padilla, H. Hirte, A. Oza, B. Clarke, B. Cohen, Michael Reedjik, Tong Zhang, S. Kamel‐Reid, S. Ivy, S. Hotte, A. Razak, E. Chen, I. Braña, M. Wizemann, Lisa Wang, L. Siu, P. Bedard (2013)
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors
Investigational New Drugs, 31
L. Luistro, Wei He, M. Smith, K. Packman, M. Vilenchik, D. Carvajal, J. Roberts, James Cai, W. Berkofsky-Fessler, Holly Hilton, Michael Linn, A. Flohr, R. Jakob-Røtne, H. Jacobsen, Kelli Glenn, D. Heimbrook, J. Boylan (2009)
Preclinical profile of a potent gamma-secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties.
Cancer research, 69 19
X Yang, W Xia, L Chen (2018)
Synergistic antitumor effect of a γ‐secretase inhibitor PF‐03084014 and sorafenib in hepatocellular carcinoma
Oncotarget, 9
Xiu-Xiu Chen, L. Gong, Rongying Ou, Zhe Zheng, Jinyan Chen, Fengfeng Xie, Xiaoxiu Huang, J. Qiu, Wen-ji Zhang, Q. Jiang, Yang Yang, Hua Zhu, Zhi Shi, Xiaojian Yan (2016)
Sequential combination therapy of ovarian cancer with cisplatin and γ-secretase inhibitor MK-0752.
Gynecologic oncology, 140 3
J. Arcaroli, Kevin Quackenbush, Alicia Purkey, R. Powell, T. Pitts, S. Bagby, Aik Tan, Benjamin Cross, K. McPhillips, Eun-Kee Song, W. Tai, Robert Winn, K. Bikkavilli, Michelle VanScoyk, S. Eckhardt, W. Messersmith (2013)
Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a γ-secretase inhibitor, in a preclinical colorectal explant model
British Journal of Cancer, 109
K. Aung, A. El-Khoueiry, K. Gelmon, B. Tran, G. Bajaj, B. He, Tian Chen, Lili Zhu, Sharath Poojary, S. Basak, Zhenhao Qi, A. Spreafico, B. Fischer, J. Desai (2018)
A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
Investigational New Drugs, 36
Y. Ikezawa, J. Sakakibara-Konishi, H. Mizugaki, S. Oizumi, M. Nishimura (2017)
Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer
International Journal of Clinical Oncology, 22
R. Xu, F. Shimizu, K. Hovinga, K. Beal, S. Karimi, L. Droms, K. Peck, P. Gutin, J. Iorgulescu, T. Kaley, L. Deangelis, E. Pentsova, C. Nolan, C. Grommes, T. Chan, D. Bobrow, A. Hormigo, J. Cross, N. Wu, N. Takebe, K. Panageas, P. Ivy, J. Supko, V. Tabar, A. Omuro (2016)
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
Clinical Cancer Research, 22
Natalie Cook, Natalie Cook, Natalie Cook, Bristi Basu, Bristi Basu, Donna Smith, A. Gopinathan, J. Evans, W. Steward, D. Palmer, D. Propper, B. Venugopal, M. Hategan, D. Anthoney, Lisa Hampson, M. Nebozhyn, D. Tuveson, Hayley Farmer-Hall, Helen Turner, R. McLeod, S. Halford, D. Jodrell, D. Jodrell (2018)
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
British Journal of Cancer, 118
A. Capobianco, P. Zagouras, C. Blaumueller, S. Artavanis-Tsakonas, J. Bishop (1997)
Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2
Molecular and Cellular Biology, 17
K. Gillman, J. Starrett, M. Parker, Kai Xie, J. Bronson, L. Marcin, K. McElhone, C. Bergstrom, Robert Mate, R. Williams, J. Meredith, C. Burton, D. Barten, J. Toyn, S. Roberts, K. Lentz, J. Houston, R. Zaczek, C. Albright, C. Decicco, J. Macor, R. Olson (2010)
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.
ACS medicinal chemistry letters, 1 3
Palaga (2003)
3019
J Immunol, 171
H. Mizugaki, J. Sakakibara-Konishi, Y. Ikezawa, J. Kikuchi, E. Kikuchi, S. Oizumi, T. Dang, M. Nishimura (2012)
γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer
British Journal of Cancer, 106
T. Lanz, Kathleen Wood, Karl Richter, C. Nolan, Stacey Becker, N. Pozdnyakov, Barbara-Anne Martin, P. Du, Christine Oborski, Douglas Wood, Tracy Brown, J. Finley, S. Sokolowski, Carol Hicks, K. Coffman, K. Geoghegan, M. Brodney, D. Liston, B. Tate (2010)
Pharmacodynamics and Pharmaco*kinetics of the γ-Secretase Inhibitor PF-3084014
Journal of Pharmacology and Experimental Therapeutics, 334
E. Pan, J. Supko, T. Kaley, N. Butowski, T. Cloughesy, Jinkyu Jung, S. Desideri, S. Grossman, X. Ye, Deric Park (2016)
Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma
Journal of Neuro-Oncology, 130
(2003)
TCRmediated notch signaling regulates proliferation and IFN-γ production in peripheral T cells
Xiong (2018)
302
Am J Cancer Res, 8
Kai Gu, Qi Li, Hongzhi Lin, Jie Zhu, J. Mo, Siyu He, Xin Lu, Xueyang Jiang, Haopeng Sun (2017)
Gamma secretase inhibitors: a patent review (2013 - 2015)
Expert Opinion on Therapeutic Patents, 27
M. Xie, Jianxing He, Chao-sheng He, Shenhai Wei (2015)
γ Secretase Inhibitor BMS‐708163 Reverses Resistance to EGFR Inhibitor via the PI3K/Akt Pathway in Lung Cancer
Journal of Cellular Biochemistry, 116
S. Tsukumo, K. Yasutomo (2018)
Regulation of CD8+ T Cells and Antitumor Immunity by Notch Signaling
Frontiers in Immunology, 9
Hyun-woo Lee, Seok-Jun Kim, I. Choi, Jaewhan Song, Kyung-Hee Chun (2015)
Targeting Notch signaling by γ-secretase inhibitor I enhances the cytotoxic effect of 5-FU in gastric cancer
Clinical & Experimental Metastasis, 32
Shu Zhang, C. Balch, M. Chan, H. Lai, D. Matei, J. Schilder, P. Yan, T. Huang, K. Nephew (2008)
Identification and characterization of ovarian cancer-initiating cells from primary human tumors.
Cancer research, 68 11
S. Yabuuchi, Shweta Pai, Nathaniel Campbell, R. Wilde, E. Oliveira, P. Korangath, M. Streppel, Z. Rasheed, M. Hidalgo, A. Maitra, N. Rajeshkumar (2013)
Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.
Cancer letters, 335 1
Hongfang Wang, C. Zang, X. Liu, J. Aster (2015)
The Role of Notch Receptors in Transcriptional Regulation
Journal of Cellular Physiology, 230

Journals /
The Oncologist /
Volume 26 Issue 4

Subject Areas

Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance, The Oncologist | DeepDyve (2024)